14 June 2019
All finalists of 2019 Premier's Awards for Health and Medical Research.
My PhD research focused on how we might exploit the immune system of plants for therapeutic applications; for example, as antibacterial, antifungal, or anti-cancer agents.
Paracetamol overdose is one of the commonest overdoses in the world. My PhD concentrated on decreasing the severe adverse effects of the antidote.
My project was at the forefront of using whole genome sequencing technology to explore the emergence of enteric pathogens. In my case, a typical enteropathic, E. Coli, which is associated with severe childhood diarrheal disease.
My research demonstrated that nutrition intake during critical illness was below what health professionals aimed for, both inside the ICU and outside on the hospital ward.
We found that schools that combined mental-health-related objectives, alongside nutrition and physical activity objectives, were able to decrease the proportion of students experiencing poor mental health.
Thousands of children die every day because they lack access to oxygen. We've been working with 12 Nigerian hospitals to improve, firstly, how they identify children who need oxygen, and secondly, work out how to get that oxygen to them.
My PhD was comprised of four mixed-method studies and resulted in five academic publications. The aim of my thesis was to explore the impact and influence of sports-betting advertising on the attitudes, behaviors, and gambling consumption intentions of young people.
Children, unlike adults, don't get preventive health care from general practice. My research found this could be changed.
Every day, our bodies are generating billions of new cells, and to balance this, they're also killing billions of cells, as well. In my PhD, I used a brand-new form of microscopy to video the mitochondria inside cells as they died.
My PhD work involved designing and conducting a national clinical trial for Australians with recurrent glioblastoma.
I found that paramedics treat less than two cardiac arrests a year, but patients treated by paramedics, with a high exposure to cardiac arrest, are 50% more likely to survive.
And I focused on how children function socially and psychologically after a stroke. By understanding factors associated with post-stroke problems, we can provide better information to clinicians and families, and for children most at risk, intervene early.
Examples of the research that I've undertaken include use of a simple blood test to screen for the risk of developing blood clots and target preventive therapy only to cancer patients at high risk, while avoiding unnecessary intervention to those at low risk.
My current focus is understanding resistance to venetoclax and developing prevention methods. This will enable us to help more patients, with leukemia and lymphoma, to live better lives for longer.
Decided to start a research study that would be informed by a First Nation relational worldview, First Nation methodology, authors, and participants.
Using a new, immune-based test, I was able to accurately predict and identify CMV infection and death in transplant patients by monitoring the immune system.
My research explored the possibility of taking a precision oncology approach in incurable breast cancer. We're understanding more about an individual person's disease.
My research aims to restore control to people with epilepsy by developing a mobile app to forecast seizures.
My research focuses on natural killer cells, also known as NK cells. NK cells are lymphocytes with the innate ability to detect and kill tumor cells, operating in a highly targeted way, suggesting that their use as an immunotherapy will result in limited off-target effects.
By examining 80 patterns and their associations with obesity and hypertension in adults who participated in the Australian Health Survey, my research contributes to evidence that can be translated into practical healthy eating messages.
I devised a multi-center, randomized clinical trial utilizing cardiac MRI and a minimally invasive procedure known as catheter ablation to restore normal rhythm in patients with atrial fibrillation and, otherwise, unexplained heart failure.
Oxaliplatin is a platinum-metal-based anti-cancer drug used in the first-line treatment for colorectal cancer. So in my PhD, I studied if and how this anti-cancer drug affects nerves, which control gastrointestinal function.
As part of my Phd, I was involved in the implementation and evaluation of the PrEPX study, which delivered PrEP to over 4,000 people across Victoria. The aim of PrEPX was to substantially reduce new HIV infections in Victoria.
My research concerned itself with the experience of infants who, with their mothers, entered into women's refuges to escape family violence.